deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 3-arm NCT04019002

Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma

Evaluating Hyperpolarized and Proton Brain Metabolism in Patients With Glioblastoma

Sponsor: National Cancer Institute (NCI)

Conditions Glioblastoma Multiforme (GBM)
Interventions Hyperpolarized 13C Pyruvate
Updated 13 times since 2019 Last updated: Dec 3, 2024 Started: Nov 19, 2019 Primary completion: Sep 30, 2025 Completion: Sep 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Glioblastoma Multiforme (GBM), this trial is ongoing. The trial is conducted by National Cancer Institute (NCI) and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Dec 2019 · 2 months · monthly snapshot~Dec 2019 – ~Jul 2020 · 7 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Jan 2023 · 11 months · monthly snapshot~Jan 2023 – ~Apr 2023 · 3 months · monthly snapshot~Apr 2023 – ~Nov 2023 · 7 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – present · 19 months · monthly snapshot

Change History

13 versions recorded

  1. Jan 2025 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

  4. Nov 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  5. Apr 2023 — Nov 2023 [monthly]

    Recruiting PHASE1

▶ Show 8 earlier versions

  1. Jan 2023 — Apr 2023 [monthly]

    Recruiting PHASE1

  2. Feb 2022 — Jan 2023 [monthly]

    Recruiting PHASE1

  3. Sep 2021 — Feb 2022 [monthly]

    Recruiting PHASE1

  4. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  5. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  6. Dec 2019 — Jul 2020 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  7. Oct 2019 — Dec 2019 [monthly]

    Not Yet Recruiting PHASE1

  8. Aug 2019 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Susan Chang
Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations